参考文献/References:
[1]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.[2]中华医学会消化内镜学分会,中国抗癌协会肿瘤内镜学专业委员会.中国早期结直肠癌筛查及内镜诊治指南(2014年,北京)[J].胃肠病学,2015(6):345-365.[3]Pop OL,Vodnar DC,Diaconeasa Z,et al.An Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps[J].Int J Mol Sci,2020,21(19):7359.[4]姚华雄,王超,杨镇.核因子-κB、环氧合酶-2在结肠腺瘤性息肉及结肠癌组织的表达及临床意义[J].中华实验外科杂志,2018,35(2):242-244.[5]Armat M,Ramezani F,Molavi O,et al.Six family of homeobox genes and related mechanisms in tumorigenesis protocols[J].Tumori,2016,2016(3):236-243. [6]张晓军.SIX1调控胶质瘤微环境致上皮细胞间质转化的分子机制及与临床相关性研究[D].广州:南方医科大学,2020.[7]魏巧,郁玮玮,赵快乐,等.Six1和Six4在食管鳞状细胞癌组织中的表达及其与预后的关系[J].中华病理学杂志,2013,42(7):446-450.[8]王静苗.Six1、FOXC2及E-cad在结肠癌中的表达及临床意义[D].承德:承德医学院,2017. [9]中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2017年版)[J].中华外科杂志,2018,56(4):241-258.[10]Wrobel P,Ahmed S.Current status of immunotherapy in metastatic colorectal cancer[J].Int J Colorectal Dis,2019,34(1):13-25. [11]Xu H,Zhang Y,Pena MM,et al.Six1 promotes colorectal cancer growth and metastasis by stimulating angiogenesis and recruiting tumor-associated macrophages[J].Carcinogenesis,2017,38(3):281-292. [12]Xia Y,Zhu Y,Ma T,et al.miR-204 functions as a tumor suppressor by regulating SIX1 in NSCLC[J].FEBS Lett,2014,588(20):3703-3712.[13]彭浩,宋立伟,周正,等.血清Six1与乳腺癌临床病理特征的关系研究[J].医学研究杂志,2016,45(6):94-96. [14]Sun SH,Liu D,Deng YT,et al.SIX1 coordinates with TGFβ signals to induce epithelial-mesenchymal transition in cervical cancer[J].Oncol Lett,2016,12(2):1271-1278. [15]Kong J,Zhou X,Liu S,et al.Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma[J].Int J Clin Exp Pathol,2014,7(6):3018-3027. [16]Blevins MA,Towers CG,Patrick AN,et al.The SIX1-EYA transcriptional complex as a therapeutic target in cancer[J].Expert Opin Ther Targets,2015,19(2):213-225.[17]Kahlert C,Lerbs T,Pecqueux M,et al.Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer[J].Int J Cancer,2015,137(9):2104-2113.[18]Yang C,Xu W,Gong J,et al.Six1 Overexpression Promotes Glucose Metabolism and Invasion Through Regulation of GLUT3, MMP2 and Snail in Thyroid Cancer Cells[J].Onco Targets Ther,2020(13):4855-4863. [19]Li Z,Tian T,Lv F,et al.Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression[J].PLoS One,2013,8(3):e59203. [20]Suen AA,Jefferson WN,Wood CE,et al.SIX1 Oncoprotein as a Biomarker in a Model of Hormonal Carcinogenesis and in Human Endometrial Cancer[J].Mol Cancer Res,2016,14(9):849-858. [21]Li G,Hu F,Luo X,et al.SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer[J].Peer J,2017(5):e3394.